Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss: The Hospital Universitario Ramón y Cajal experience and review of the literature

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 11, 2013, Pages 2823-2832

  Labatut, Tomás ^a   Daza, María José ^a   Alonso, Antonio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Hearing recovery criteria; Idiopathic; Intratympanic steroids; Methylprednisolone; Sensorineural hearing loss; Sudden sensorineural hearing loss; Transtympanic steroids; Treatment

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; UNCLASSIFIED DRUG; URBASON SOLUB;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG SAFETY; EARDRUM PERFORATION; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS; MALE; MULTIPLE CYCLE TREATMENT; MYRINGOPLASTY; OTALGIA; OUTCOME ASSESSMENT; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; SCORING SYSTEM; SPEECH AUDIOMETRY; STEROID THERAPY; SUDDEN DEAFNESS; UNIVERSITY HOSPITAL; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; COHORT STUDIES; FEMALE; HEARING LOSS, SUDDEN; HUMANS; INJECTIONS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885948874     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2306-y     Document Type: Article

References (47)

1. Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 133(6):573-581
2. Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg 133(6):582-586
3. Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106(12):772-776
4. Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 94(5 Pt 1):664-666
5. Byl FM Jr (1984) Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 94(5 Pt 1):647-661
6. Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258(9):477-480
7. Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86(4 Pt 1):463-480
8. Hamid M, Trune D (2008) Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 16(5):434-440
9. Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109(7 Pt 2):1-17
10. Chandrasekhar SS (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22(1):18-23
11. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N (2005) Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 133(2):251-259
12. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134(6):940-945
13. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF (2007) Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117(1):3-15
14. Kakehata S, Sasaki A, Oji K, Futai K, Ota S, Makinae K et al (2006) Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 27(5):604-608
15. Kara E, Cetik F, Tarkan O, Surmelioglu O (2010) Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 267(5):701-707
16. Filipo R, Covelli E, Balsamo G, Attanasio G (2010) Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol 130(11):1209-1213
17. Tsai YJ, Liang JG, Wu WB, Ding YF, Chiang RP, Wu SM (2011) Intratympanic injection with dexamethasone for sudden sensorineural hearing loss. J Laryngol Otol 125(2):133-137
18. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM et al (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146(3 Suppl):S1-S35
19. Furuhashi A, Matsuda K, Asahi K, Nakashima T (2002) Sudden deafness: long-term follow-up and recurrence. Clin Otolaryngol Allied Sci 27(6):458-463
20. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma) (1995) American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 113(3):179-180
21. Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A (2011) Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol 32(1):29-35
22. Plaza G, Herraiz C (2007) Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 137(1):74-78
23. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL (2001) Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 22(4):475-479
24. Lefebvre PP, Staecker H (2002) Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 122(7):698-702
25. Dispenza F, Amodio E, De Stefano A, Gallina S, Marchese D, Mathur N et al (2011) Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study. Eur Arch Otorhinolaryngol 268(9):1273-1278
26. Hong SM, Park CH, Lee JH (2009) Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg 141(5):579-583
27. Banerjee A, Parnes LS (2005) Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 26(5):878-881
28. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ et al (2011) Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 305(20):2071-2079
29. Han CS, Park JR, Boo SH, Jo JM, Park KW, Lee WY et al (2009) Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg 141(5):572-578
30. Robey AB, Morrow T, Moore GF (2010) Systemic side effects of transtympanic steroids. Laryngoscope 120(Suppl 4):S217
31. Borden RC, Saunders JE, Berryhill WE, Krempl GA, Thompson DM, Queimado L (2011) Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neurootol 16(1):1-11
32. Gouveris H, Selivanova O, Mann W (2005) Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 262(2):131-134
33. Banerjee A, Parnes LS (2004) The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption. Otolaryngol Clin North Am 37(5):1035-1051
34. Nagura M, Iwasaki S, Wu R, Mizuta K, Umemura K, Hoshino T (1999) Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol 366(1):47-53
35. Stokroos RJ, Albers FW, Schirm J (1998) The etiology of idiopathic sudden sensorineural hearing loss. Experimental herpes simplex virus infection of the inner ear. Am J Otol 19(4):447-452
36. Tabuchi K, Oikawa K, Uemaetomari I, Tsuji S, Wada T, Hara A (2003) Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear Res 180(1-2):51-56
37. Yao X, Buhi WC, Alvarez IM, Curtis LM, Rarey KE (1995) De novo synthesis of glucocorticoid hormone regulated inner ear proteins in rats. Hear Res 86(1-2):183-188
38. Trune DR, Wobig RJ, Kempton JB, Hefeneider SH (1999) Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse. Hear Res 137(1-2):160-166
39. Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17(4):529-536
40. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29(3):393-405
41. Kronenberg J, Almagor M, Bendet E, Kushnir D (1992) Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 102(1):65-68
42. Heiden C, Porzsolt F, Biesinger E, Hoing R (2000) Spontaneous remission of sudden deafness. HNO 48(8):621-623
43. Weinaug P (2001) How high is the rate of spontaneous healing of sudden deafness? Comments on the contribution "Spontaneous healing of sudden deafness". HNO 49(6):431-432
44. Laird N, Wilson WR (1983) Predicting recovery from idiopathic sudden hearing loss. Am J Otolaryngol 4(3):161-164
45. Labus J, Breil J, Stutzer H, Michel O (2010) Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope 120(9):1863-1871
46. Zernotti ME, Paoletti OA, Zernotti M, Martinez ME, Roques-Revol M, Prina AC (2009) Intratympanic dexamethasone as therapeutic option in sudden sensorineural hearing loss. Acta Otorrinolaringol Esp 60(2):99-103
47. Wycherly BJ, Thompkins JJ, Kim HJ (2011) Early posttreatment audiometry underestimates hearing recovery after intratympanic steroid treatment of sudden sensorineural hearing loss. Int J Otolaryngol 2011:465831